| Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704) |
|---|
| 09/24/2002 | US6455523 Inhibitors of farnesyl protein transferase |
| 09/19/2002 | WO2002014311A3 Urea compounds and methods of uses |
| 09/18/2002 | EP1240167A1 Optically active isomers of quinine and quinidine and their respective biological action |
| 09/18/2002 | CN1370048A Azabicyclo and azacyclo oxime and amine compounds as pesticides |
| 09/12/2002 | WO2002070653A2 Peptide deformylase inhibitors |
| 09/12/2002 | WO2002070494A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers |
| 09/12/2002 | WO2002070479A1 N-4-piperidinyl compounds as ccr5 modulators |
| 09/12/2002 | US20020128271 N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 09/11/2002 | CN1368848A Heterocyclic spiro compounds as pesticides |
| 09/05/2002 | US20020123507 Bicyclic derivatives |
| 09/04/2002 | EP1235826A1 Quinuclidine acrylamides |
| 09/04/2002 | EP1235803A1 Urea compounds having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235802A1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 09/03/2002 | US6444701 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 08/29/2002 | US20020119972 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases |
| 08/29/2002 | DE10106971A1 Arzneimittelformulierung die einen muskarinischen Agonisten enthält Pharmaceutical formulation containing a muscarinic agonist |
| 08/28/2002 | EP1233964A1 New use and novel n-azabicyclo-amide derivatives |
| 08/28/2002 | CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 08/22/2002 | WO2002064124A2 Medicament formulation containing a muscarinic agonist |
| 08/22/2002 | US20020115678 Compounds, compositions and methods for treating antibiotic-resistant infections |
| 08/22/2002 | CA2434976A1 Medicament formulation containing a muscarinic agonist |
| 08/20/2002 | US6436386 Hydroxyapatite-targeting poly (ethylene glycol) and related polymers |
| 08/14/2002 | EP1230243A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 08/14/2002 | EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/14/2002 | EP0759920B1 Derivatives of quinuclidine n-oxide as muscarinic receptor ligands |
| 08/13/2002 | US6433168 Chemical intermediate for mequitazine; antihistamines |
| 08/13/2002 | US6432975 Aromatic alkylene azobicyclic compounds as nicotinic receptor antagonists; antidepressants; nervous system disorder treatment |
| 08/08/2002 | US20020107392 Quinolinone derivatives |
| 07/31/2002 | EP1225955A1 Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 07/30/2002 | CA2078039C Process for the production of lactams |
| 07/25/2002 | WO2002057254A1 Compositions for prevention or treatment of hepatopathy |
| 07/25/2002 | CA2435141A1 Compositions for prevention or treatment of hepatopathy |
| 07/24/2002 | EP0900218B1 Heterocyclic compounds |
| 07/23/2002 | US6423713 Substituted pyrazoles as p38 kinase inhibitors |
| 07/18/2002 | WO2002055515A1 Chemical derivatives and their use as anti-telomerase agent |
| 07/18/2002 | WO2002016358A3 Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| 07/18/2002 | WO2002016355A3 Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands |
| 07/18/2002 | WO2002002556A3 AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS α4 INTEGRIN ANTAGONISTS |
| 07/18/2002 | CA2433723A1 Chemical derivatives and their use as anti-telomerase agent |
| 07/17/2002 | EP1223169A1 Agent for potentiating nerve growth factor activity containg 1,2-ethanediol derivate or salt thereof |
| 07/17/2002 | EP0888340B1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 07/17/2002 | EP0882044B1 1,4-dihydropyridine compounds as bradykinin antagonists |
| 07/17/2002 | CN1087737C Dihygropyridine derivatives as bradykinin ant agonists |
| 07/11/2002 | WO2002053564A2 Quinuclidine derivatives and their use as m3 antagonists |
| 07/11/2002 | US20020091136 Pharmaceutical compositions containing cinchonine dichlorhydrate |
| 07/11/2002 | US20020091135 Quinuclidine-substituted heteroaryl moieties for treatment of disease |
| 07/11/2002 | US20020091115 Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists |
| 07/10/2002 | EP1220854A2 Novel tropane analogs |
| 07/10/2002 | EP1220840A2 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 07/10/2002 | CN1358188A Diphosphate salt of A4'-substituted-9-deoxo-9A-aza 9A-homoerythromycin derivative and its pharmaceutical composition |
| 07/04/2002 | WO2002051841A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 07/04/2002 | CA2441896A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 07/03/2002 | EP1218349A2 Method for selectively dissociating cyclic carboxylic acid anhydrides |
| 07/03/2002 | CN1356991A Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors |
| 07/02/2002 | US6413978 Basic derivatives of benz[e] isoindol-1-ones and pyrrolo[3,4-c] quinolin-1-ones with 5-HT3-antagonistic activity, their preparation and their therapeutic use |
| 07/02/2002 | US6413947 Antiinflammatory agents; rheumatic diseases; anticholesterol agents |
| 06/26/2002 | EP1217001A1 Quinuclidine compounds and drugs containing the same as the active ingredient |
| 06/20/2002 | WO2002048150A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof |
| 06/13/2002 | WO2002018334A3 Sodium channel modulators |
| 06/13/2002 | WO2002015662A3 Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists |
| 06/13/2002 | WO1999059957A9 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 06/12/2002 | EP1213289A1 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 06/12/2002 | EP1212301A1 Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 06/12/2002 | EP1211940A1 Azabicyclo and azacyclo oxime and amine compounds as pesticides |
| 06/12/2002 | EP0984778B1 Neuropeptide-y ligands |
| 06/12/2002 | EP0885221B1 Azabicyclic esters of carbamic acids useful in therapy |
| 06/12/2002 | CN1353712A Polymorphs of crystalline (2-benzhydryl-2-azabicyclo [2.2.2] OCT-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as NK-1 receptor antagonists |
| 06/12/2002 | CN1353711A Polymorphs of crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions |
| 06/12/2002 | CN1353702A Adamantane derivatives |
| 06/11/2002 | US6403596 Substituted pyridones having cytokine inhibitory activity |
| 06/11/2002 | CA2169838C Antipsychotic method |
| 06/06/2002 | WO2002044176A1 3-substituted quinuclidines and their use as nicotinic agonists |
| 06/06/2002 | WO2002044144A2 Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds |
| 05/30/2002 | WO2002020526A3 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 05/30/2002 | WO2002017358A3 Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists) |
| 05/30/2002 | WO2002016357A3 Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| 05/29/2002 | EP1209157A1 Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds |
| 05/29/2002 | DE10028443C1 Production of optically active 3,3-diaryl-propylamine derivatives comprises six step process from 4-hydroxybenzoic acid or alkyl 4-hydroxybenzoate and cinnamic acid |
| 05/29/2002 | CN1085529C Use of [R-(Z)]-alpha-(methoxyimino)-alpha-[1-azabicyclw[2.2.2.]oct-3-yl] acetonitrile to reduce amyloid beta A4 formation in Alzheimers disease |
| 05/23/2002 | WO2002040058A2 Hydroxyapatite-targeting poly(ethylene glycol) and related polymers |
| 05/21/2002 | US6392103 Using organometallic compound as catalyst |
| 05/16/2002 | WO2002038528A1 Pleuromutilin derivatives with antimicrobial activity |
| 05/16/2002 | WO2002016356A3 Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| 05/16/2002 | US20020058652 Pharmaceutical compositions and methods for use |
| 05/15/2002 | CN1349527A Substituted benzolactam compounds |
| 05/14/2002 | US6387925 Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions |
| 05/14/2002 | US6387395 N-[1, (1-1) -dialkyloxy] - and N- [1, (1-1) -dialkenyloxy]- alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| 05/08/2002 | CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor |
| 05/02/2002 | US20020052503 Substituted benzolactam compounds as substance p antagonists |
| 05/02/2002 | US20020052389 Quinuclidine-substituted aryl compounds for treatment of disease |
| 05/02/2002 | US20020052351 Novel medical use for tachykinin antagonists |
| 05/02/2002 | US20020052348 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 05/02/2002 | EP1200440A1 Quinuclidine derivatives for treatment of neurological disorders |
| 05/02/2002 | EP1200431A2 Quinuclidine derivatives and their use as muscarinic m3 receptor ligands |
| 05/02/2002 | EP0607164B1 Fused tricyclic nitrogen containing heterocycles as substance p receptor antagonists |
| 04/30/2002 | US6380396 Chemical intermediates for antiinflammatory agents |
| 04/25/2002 | WO2002032863A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 04/25/2002 | US20020049225 Quinuclidine-substituted aryl compounds for treatment of disease |
| 04/25/2002 | US20020049195 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc. |
| 04/25/2002 | CA2422717A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |